市場調查報告書
商品編碼
1465069
病理資訊學市場:按產品類型、應用和最終用戶分類 - 全球預測 2024-2030Pathology Informatics Market by Product Type, Application, End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年病理資訊學市場規模為13.3億美元,預計2024年將達到14.4億美元,2030年將達到22.9億美元,複合年成長率為7.98%。
病理資訊學是一個交叉學科領域,專注於應用資訊科技來收集、儲存、分析和普及病理資料。這包括管理與病理學領域的患者護理、研究和教育活動相關的資訊。這包括各種主題,包括實驗室資訊系統 (LIS)、病理標本的數位成像和分析、資料探勘和管理、互通性和標準化以及遠端病理學。慢性病的增加需要病理資訊學等先進的診斷技術。此外,對高效實驗室管理系統處理不斷增加的病理資料的需求不斷成長,正在擴大病理資訊學的範圍。對需要詳細病理分析的個人化醫療和標靶治療的日益關注正在擴大病理資訊學的應用。然而,數位病理系統和相關基礎設施的初始投資成本較高,加上缺乏病理學和資訊學方面的熟練專業人員,為市場成長帶來了挑戰。然而,用於預測分析和提高診斷準確性的人工智慧和機器學習模型的市場開拓為市場成長提供了機會。病理資訊學系統已整合到醫療保健 IT 生態系統中,以實現全面的患者照護,擴大了病理資訊學解決方案的採用範圍。
主要市場統計 | |
---|---|
基準年[2023] | 13.3億美元 |
預測年份 [2024] | 14.4億美元 |
預測年份 [2030] | 22.9億美元 |
複合年成長率(%) | 7.98% |
數位病理系統普及,提升慢性病診斷準確性
數位病理學系統是病理學資訊學的新興類別,主要用於儲存、管理和分析從玻片掃描獲得的數位影像。這些系統正在徹底改變傳統的病理學工作流程,提供更高的診斷準確性、遠端存取玻片以及跨地理邊界的協作機會。數位病理學系統的採用正在強勁成長,特別是隨著對高效診斷技術的需求不斷增加以及慢性病患病率的上升。實驗室資訊管理系統 (LIMS) 是一種軟體解決方案,透過管理資料、工作流程和通訊來簡化實驗室業務。它自動執行檢體管理、測試、結果分析和合規管理等任務,在確保實驗室效率和有效性方面發揮關鍵作用。 LIMS 具有高度適應性,可用於醫療保健以外的各種行業,例如環境、製藥和生物技術。實驗室資訊系統 (LIS) 專門用於臨床實驗室,專注於管理患者資料、實驗室工作流程和診斷資訊。與可適應更廣泛實驗室類型的 LIMS 不同,LIS 專門支援臨床診斷並提供用於訂單輸入、結果輸入、檢體追蹤和患者統計的工具。病理影像處理軟體支援病理影像的可視化、解釋和分析。它允許病理學家使用縮放、平移和註釋工具在電腦上檢查幻燈片影像,從而在數位病理診斷中發揮重要作用。該軟體透過先進的影像分析技術(包括用於模式識別的機器學習演算法)提高診斷準確性。對病理影像處理軟體的需求是由促進遠距離診斷、教育和協作研究的功能所驅動的。病理資訊學工作流程管理解決方案旨在最佳化實驗室業務、減少人工錯誤並縮短週轉時間。這些解決方案管理從檢體接受到結果交付的整個工作流程,確保所有流程快速且有效率地完成。它對於標準化業務、減少浪費和提高實驗室整體生產力至關重要。實驗室業務的增加和無縫整合業務的需求是採用工作流程管理解決方案的關鍵驅動力。
最終用戶:診斷實驗室採用率高,可有效管理大量資料
診斷實驗室是病理資訊學的關鍵最終用戶,利用複雜的系統有效管理大量資料。這些實驗室擴大實施數位病理學解決方案,以簡化工作流程、提高診斷準確性並縮短週轉時間。病理資訊學整合可以輕鬆儲存、搜尋和分析病理資料和影像,方便遠端檢查和第二意見。醫院和診所依靠病理資訊學來提供更快、更準確的診斷服務並改善患者照護。即時存取病理資料和影像有利於多學科檢查和決策流程,極大地受益於病理數位化。此外,將病理資料整合到電子健康記錄系統中可以為醫療保健提供者提供患者健康史的全面視圖,從而提高護理的連續性。研究機構和學術中心處於利用病理資訊學推進醫學研究和教育的前沿。這些機構利用複雜的資料分析工具和計算演算法對疾病模式、治療結果和流行病學趨勢進行大規模研究。病理標本的數位化也有助於跨機構共用罕見病例和教育資源,促進協作研究和學習。
區域洞察
以美國和加拿大為中心的美洲地區因其完善的醫療基礎設施、強大的數位化舉措以及對研發的高度重視而成為病理資訊學的重要市場。數位病理系統的引入,加上人工智慧和機器學習演算法的引入,正在推動市場向前發展。由於醫療保健系統、法規環境和技術採用水準的不同,歐洲、中東和非洲地區的市場是異質的。西歐在市場成熟度方面處於領先地位,並且正在經歷數位病理學的強勁成長。同時,由於醫療成本上升和數位轉型舉措,中東和非洲成為具有潛力的新興市場。由於人口眾多、慢性病數量不斷增加以及醫療保健產業快速發展,亞太地區的病理資訊學呈現快速成長。中國、日本和澳洲等國家處於採用數位病理解決方案的前沿,以滿足對先進診斷服務不斷成長的需求。
FPNV定位矩陣
FPNV 定位矩陣對於評估病理資訊學市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對病理資訊學市場中供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.病理資訊學市場的市場規模和預測是多少?
2.在病理資訊學市場的預測期內,有哪些產品、細分市場、應用程式和領域需要考慮投資?
3.病理資訊學市場的技術趨勢和法規結構是什麼?
4.病理資訊學市場主要供應商的市場佔有率是多少?
5. 進入病理資訊學市場的合適型態和策略手段是什麼?
[190 Pages Report] The Pathology Informatics Market size was estimated at USD 1.33 billion in 2023 and expected to reach USD 1.44 billion in 2024, at a CAGR 7.98% to reach USD 2.29 billion by 2030.
Pathology informatics is a multidisciplinary field that focuses on the application of information technology to the collection, storage, analysis, and dissemination of pathology data. This includes the management of information related to patient care, research, and educational endeavors within the realm of pathology. It includes a range of topics, including laboratory information systems (LIS), digital imaging and analysis of pathology specimens, data mining and management, interoperability and standards, and telepathology, among others. The increasing prevalence of chronic diseases necessitates advanced diagnostic techniques such as pathology informatics. Moreover, the rising demand for efficient laboratory management systems to cope with the expanding volume of pathology data has created added scope for pathology informatics. Enhanced focus on personalized medicine and targeted therapies, requiring detailed pathological analysis, expand the applications for pathology informatics. However, high initial investment costs for digital pathology systems and related infrastructure, coupled with the scarcity of skilled professionals proficient in both pathology and informatics, challenge the growth of the market. Nevertheless, the development of AI and machine learning models for predictive analytics and improved diagnostic accuracy provides an opportunistic view for market growth. Integration of pathology informatics systems within broader healthcare IT ecosystems for holistic patient care created an expanded scope for the adoption of pathology informatics solutions.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 1.33 billion |
Estimated Year [2024] | USD 1.44 billion |
Forecast Year [2030] | USD 2.29 billion |
CAGR (%) | 7.98% |
Type: Proliferation of digital pathology systems for enhanced diagnostic accuracy against rising chronic diseases
Digital Pathology Systems are an emergent category within pathology informatics, primarily designed for storing, managing, and analyzing digital images obtained from slide scans. These systems have revolutionized the traditional pathology workflow, offering enhanced diagnostic accuracy, remote access to slides, and collaborative opportunities across geographic boundaries. The adoption of digital pathology systems has seen significant growth, especially with the increased demand for efficient diagnostic techniques and the rising prevalence of chronic diseases. Laboratory Information Management Systems (LIMS) are software solutions that streamline laboratory operations by managing data, workflows, and communications. They are critical in ensuring the efficiency and effectiveness of laboratories, automating tasks such as sample management, testing, results analysis, and compliance management. LIMS are highly adaptable, catering to various industries beyond healthcare, including environmental, pharmaceutical, and biotechnology. Laboratory Information Systems (LIS) are tailored specifically for the clinical laboratory sector, focusing on managing patient data, laboratory workflow processes, and diagnostic information. Unlike LIMS, which can serve a broader range of laboratory types, LIS specifically supports clinical diagnostics, providing tools for order entry, result entry, specimen tracking, and patient demographics. Pathology Imaging Software supports the visualization, interpretation, and analysis of pathology images. It plays a crucial role in digital pathology by enabling pathologists to examine slide images on computers with zooming, panning, and annotating tools. This software enhances diagnostic accuracy through advanced image analysis techniques including machine learning algorithms for pattern recognition. The demand for pathology imaging software is rising, attributed to its capability to facilitate remote diagnostics, teaching, and collaborative research. Workflow management solutions in pathology informatics are designed to optimize laboratory operations, reduce manual errors, and improve turnaround times. These solutions manage the entire workflow from specimen receipt to result delivery, ensuring that all processes are completed promptly and efficiently. They are integral in standardizing operations, reducing waste, and enhancing overall laboratory productivity. Increasing laboratory workload and the need for seamlessly integrated operations are significant drivers for adopting workflow management solutions.
End-User: High adoption in diagnostic laboratories to manage a vast amount of data efficiently
Diagnostic laboratories represent a pivotal end-user in pathology informatics, utilizing advanced systems to manage a vast amount of data efficiently. These laboratories are increasingly adopting digital pathology solutions to streamline workflow, enhance diagnostic accuracy, and improve turnaround times. The integration of pathology informatics allows for better storage, retrieval, and analysis of pathological data and images, facilitating remote consultations and second opinions. Hospitals and clinics utilize pathology informatics mainly to enhance patient care through faster and more accurate diagnostic services. These settings benefit significantly from the digitization of pathology as it enables real-time access to pathological data and images, facilitating multidisciplinary consultations and decision-making processes. Additionally, the integration of pathology data into the electronic health record systems improves the continuity of care by facilitating healthcare providers with a comprehensive view of patient health history. Research institutes and academic centers are at the forefront of utilizing pathology informatics for the purpose of advancing medical research and education. These entities leverage sophisticated data analysis tools and computational algorithms to conduct large-scale studies on disease patterns, treatment outcomes, and epidemiological trends. The digitization of pathology specimens also facilitates the sharing of rare cases and educational resources across institutions, promoting collaborative research and learning.
Regional Insights
The Americas region, particularly the United States and Canada, represents a significant market for Pathology Informatics, driven by well-established healthcare infrastructure, robust digitization initiatives, and a strong focus on research and development. The adoption of digital pathology systems, coupled with the infusion of AI & machine learning algorithms, has propelled the market forward. The market in the EMEA region shows variability due to diverse healthcare systems, regulatory environments, and levels of technology adoption. Western Europe leads in market maturity, with considerable growth in digital pathology, whereas the Middle East and Africa are emerging markets with potential due to increasing healthcare expenditure and digital transformation initiatives. The Asia Pacific region showcases rapid growth for Pathology Informatics due to its large population base, increasing incidence of chronic diseases, and rapidly evolving healthcare sector. Countries including China, Japan, and Australia are at the forefront of adopting digital pathology solutions to meet the growing demand for advanced diagnostic services.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Pathology Informatics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pathology Informatics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Pathology Informatics Market, highlighting leading vendors and their innovative profiles. These include 3DHISTECH Ltd., Abbott Laboratories, Agilent Technologies, Inc., Aiforia Technologies PLC, Capgemini SE, Clinisys, Inc., Corista LLC, Danaher Corporation, F. Hoffmann-La Roche AG, GE Healthcare, Huron Digital Pathology, Illumina, Inc., Indica Labs, Infosys Limited, International Business Machines Corporation, Koninklijke Philips N.V., Meteor Biotech., Olympus Corporation, OptraSCAN, Inc., Paige AI, Inc., PathAI, PerkinElmer Inc., Proscia Inc., Scitara Corporation, Siemens Healthineers, Thermo Fisher Scientific, Inc., and Xybion Digital Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Pathology Informatics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pathology Informatics Market?
3. What are the technology trends and regulatory frameworks in the Pathology Informatics Market?
4. What is the market share of the leading vendors in the Pathology Informatics Market?
5. Which modes and strategic moves are suitable for entering the Pathology Informatics Market?